ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 51 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2018. The put-call ratio across all filers is 1.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $20,000 | +53.8% | 25,000 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $13,000 | +44.4% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $9,000 | -50.0% | 25,000 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $18,000 | 0.0% | 25,000 | 0.0% | 0.00% | -25.0% |
| Q3 2019 | $18,000 | -50.0% | 25,000 | -8.8% | 0.00% | -42.9% |
| Q2 2019 | $36,000 | +620.0% | 27,421 | +1032.6% | 0.01% | +600.0% |
| Q1 2019 | $5,000 | 0.0% | 2,421 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $5,000 | -80.8% | 2,421 | -67.4% | 0.00% | -85.7% |
| Q3 2018 | $26,000 | +8.3% | 7,421 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $24,000 | -4.0% | 7,421 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $25,000 | -28.6% | 7,421 | 0.0% | 0.01% | -36.4% |
| Q4 2017 | $35,000 | -10.3% | 7,421 | 0.0% | 0.01% | -15.4% |
| Q3 2017 | $39,000 | -30.4% | 7,421 | -25.8% | 0.01% | -40.9% |
| Q2 2017 | $56,000 | +21.7% | 10,000 | 0.0% | 0.02% | -8.3% |
| Q1 2017 | $46,000 | +35.3% | 10,000 | 0.0% | 0.02% | +14.3% |
| Q4 2016 | $34,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|